pLenti-EmGFP-LATS2/1 KD Citations (3)

Originally described in: Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in the muscle injury model.
Yang Z, Nakagawa K, Sarkar A, Maruyama J, Iwasa H, Bao Y, Ishigami-Yuasa M, Ito S, Kagechika H, Hata S, Nishina H, Abe S, Kitagawa M, Hata Y Mol Cell Biol. 2014 Feb 18. PubMed Journal

---

Articles Citing pLenti-EmGFP-LATS2/1 KD

Articles
The Hippo pathway regulates human megakaryocytic differentiation. Lorthongpanich C, Jiamvoraphong N, Supraditaporn K, Klaihmon P, U-Pratya Y, Issaragrisil S. Thromb Haemost. 2017 Jan 5;117(1):116-126. doi: 10.1160/TH16-07-0564. Epub 2016 Oct 27. PubMed
WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth. Gargini R, Escoll M, Garcia E, Garcia-Escudero R, Wandosell F, Anton IM. Cell Rep. 2016 Nov 15;17(8):1962-1977. doi: 10.1016/j.celrep.2016.10.064. PubMed
p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth. Ouyang H, Luong P, Frodin M, Hansen SH. Oncogene. 2020 Aug;39(33):5570-5587. doi: 10.1038/s41388-020-1385-2. Epub 2020 Jul 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.